Related Experiment Video
Updated: Jan 12, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
MYH6 in Congenital Heart Defects: A Genotype-Phenotype Characterization in a French Cohort
Elise Daire1,2,3, Clément Sauvestre4, Antoine Moktadir5
1Pediatric Cardiology Department, Amiens University Hospital, Amiens, France. daire.elise@chu-amiens.fr.
MYH6 gene variants are linked to congenital heart defects (CHD), predominantly left heart issues and persistent left superior vena cava. Genetic testing for MYH6 is recommended, especially when family history is unclear.
Area of Science:
- Cardiovascular Genetics
- Pediatric Cardiology
- Medical Genetics
Background:
- Congenital heart defects (CHD) are common infant anomalies with significant morbidity and mortality.
- Genetic and environmental factors contribute to CHD development.
- MYH6 gene variants are implicated as potential major genetic factors in CHD.
Purpose of the Study:
- To characterize cardiac phenotypes in individuals diagnosed with CHD and carrying MYH6 variants.
- To investigate the association between MYH6 variants and specific CHD subtypes.
- To assess the prevalence of persistent left superior vena cava (LSVC) in this cohort.
Main Methods:
- Retrospective analysis of clinical and family data from 29 individuals with CHD and identified MYH6 variants across four French genetics laboratories.
- Detailed phenotyping and variant analysis.
- Family screening to evaluate penetrance and expressivity.
Main Results:
- Left heart defects were the predominant phenotype (68.9%), including hypoplastic left heart syndrome, left heart obstruction, and coarctation of the aorta.
- Persistent left superior vena cava (LSVC) was observed in 37.9% of cases, a significantly higher prevalence than reported in general literature.
- Most MYH6 variants were heterozygous, missense, and inherited, with evidence of incomplete penetrance and variable expressivity.
Conclusions:
- MYH6 variants are associated with a spectrum of CHD, notably left heart defects and LSVC.
- The findings support the broader molecular screening of the MYH6 gene in patients with CHD.
- Consideration for MYH6 screening is particularly relevant when familial recurrence of CHD is uncertain.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
X-linked Traits
Genetic Lingo
Cardiomyopathy I: Introduction and Classification
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pedigree Analysis

